Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

In Reply.

Awad H, Bourekas E, Hosam ES, Tili E.

Anesthesiology. 2019 Feb;130(2):353. doi: 10.1097/ALN.0000000000002521. No abstract available.

PMID:
30688789
2.

[Roles of miR-155 microRNA in dementia associated with Down's syndrome].

Nuovo G, Tili E, Awad H, Michaille JJ.

Med Sci (Paris). 2018 Nov;34(11):922-924. doi: 10.1051/medsci/2018231. Epub 2018 Dec 10. French. No abstract available.

PMID:
30526830
3.

miR-155 expression in antitumor immunity: The higher the better?

Michaille JJ, Awad H, Fortman EC, Efanov AA, Tili E.

Genes Chromosomes Cancer. 2019 Apr;58(4):208-218. doi: 10.1002/gcc.22698. Review.

PMID:
30382602
4.

MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol.

Michaille JJ, Piurowski V, Rigot B, Kelani H, Fortman EC, Tili E.

Medicines (Basel). 2018 Jul 9;5(3). pii: E74. doi: 10.3390/medicines5030074. Review.

5.

MiR-155 deletion reduces ischemia-induced paralysis in an aortic aneurysm repair mouse model: Utility of immunohistochemistry and histopathology in understanding etiology of spinal cord paralysis.

Awad H, Bratasz A, Nuovo G, Burry R, Meng X, Kelani H, Brown M, Ramadan ME, Williams J, Bouhliqah L, Popovich PG, Guan Z, Mcallister C, Corcoran SE, Kaspar B, Michele Basso D, Otero JJ, Kirsch C, Davis IC, Croce CM, Michaille JJ, Tili E.

Ann Diagn Pathol. 2018 Oct;36:12-20. doi: 10.1016/j.anndiagpath.2018.06.002. Epub 2018 Jun 18.

6.

microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia.

Tili E, Mezache L, Michaille JJ, Amann V, Williams J, Vandiver P, Quinonez M, Fadda P, Mikhail A, Nuovo G.

Ann Diagn Pathol. 2018 Jun;34:103-109. doi: 10.1016/j.anndiagpath.2018.03.006. Epub 2018 Mar 26.

PMID:
29661714
7.

Friend or Foe: MicroRNAs in the p53 network.

Luo Z, Cui R, Tili E, Croce C.

Cancer Lett. 2018 Apr 10;419:96-102. doi: 10.1016/j.canlet.2018.01.013. Epub 2018 Jan 9. Review.

PMID:
29330109
8.

Images in Anesthesiology: Spinal Subdural Hematoma after Spinal Drain for Endovascular Thoracic Aortic Aneurysm Repair.

Awad H, Huang TJ, Tili E, Bourekas E.

Anesthesiology. 2018 May;128(5):1004. doi: 10.1097/ALN.0000000000001995. No abstract available.

PMID:
29210707
9.

MicroRNAs in intestinal barrier function, inflammatory bowel disease and related cancers-their effects and therapeutic potentials.

Tili E, Michaille JJ, Piurowski V, Rigot B, Croce CM.

Curr Opin Pharmacol. 2017 Dec;37:142-150. doi: 10.1016/j.coph.2017.10.010. Epub 2017 Nov 15. Review.

10.

Spinal cord injury after thoracic endovascular aortic aneurysm repair.

Awad H, Ramadan ME, El Sayed HF, Tolpin DA, Tili E, Collard CD.

Can J Anaesth. 2017 Dec;64(12):1218-1235. doi: 10.1007/s12630-017-0974-1. Epub 2017 Oct 10. Review.

11.

UTP - Gated Signaling Pathways of 5-HT Release from BON Cells as a Model of Human Enterochromaffin Cells.

Liñán-Rico A, Ochoa-Cortes F, Zuleta-Alarcon A, Alhaj M, Tili E, Enneking J, Harzman A, Grants I, Bergese S, Christofi FL.

Front Pharmacol. 2017 Jul 13;8:429. doi: 10.3389/fphar.2017.00429. eCollection 2017.

12.

Fluoroscopic-Guided Lumbar Spinal Drain Insertion for Thoracic Aortic Aneurysm Surgery.

Awad H, Ramadan ME, Tili E, Hackett K, Bourekas EC.

Anesth Analg. 2017 Oct;125(4):1219-1222. doi: 10.1213/ANE.0000000000001685.

PMID:
28002169
13.

ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5.

Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH, Nakanishi K, Fassan M, Luo Z, Shi G, Tili E, Kutay H, Lovat F, Vicentini C, Huang HL, Wang SW, Kim T, Zanesi N, Jeon YJ, Lee TJ, Guh JH, Hung MC, Ghoshal K, Teng CM, Peng Y, Croce CM.

Cancer Cell. 2016 Nov 14;30(5):723-736. doi: 10.1016/j.ccell.2016.10.001.

15.

A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital.

Morroni G, Brenciani A, Vincenzi C, Barocci S, Tili E, Manso E, Mingoia M, Menzo S, Varaldo PE, Giovanetti E.

J Hosp Infect. 2016 Oct;94(2):203-6. doi: 10.1016/j.jhin.2016.07.012. Epub 2016 Jul 25. No abstract available.

PMID:
27546457
16.

Quaking and miR-155 interactions in inflammation and leukemogenesis.

Tili E, Chiabai M, Palmieri D, Brown M, Cui R, Fernandes C, Richmond T, Kim T, Sheetz T, Sun HL, Lagana A, Veneziano D, Volinia S, Rassenti L, Kipps T, Awad H, Michaille JJ, Croce CM.

Oncotarget. 2015 Sep 22;6(28):24599-610. doi: 10.18632/oncotarget.5248.

17.

MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.

Cui R, Kim T, Fassan M, Meng W, Sun HL, Jeon YJ, Vicentini C, Tili E, Peng Y, Scarpa A, Liang G, Zhang YK, Chakravarti A, Croce CM.

Oncotarget. 2015 Sep 8;6(26):21802-15.

18.

MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.

Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan M, Jeon YJ, Li B, Vicentini C, Peng Y, Lee TJ, Luo Z, Liu L, Xu D, Tili E, Jin V, Middleton J, Chakravarti A, Lautenschlaeger T, Croce CM.

Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4288-97. doi: 10.1073/pnas.1502068112. Epub 2015 Jul 17.

19.

Regulated Expression of miR-155 is Required for iNKT Cell Development.

Burocchi A, Pittoni P, Tili E, Rigoni A, Costinean S, Croce CM, Colombo MP.

Front Immunol. 2015 Mar 30;6:140. doi: 10.3389/fimmu.2015.00140. eCollection 2015.

20.

Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.

Kim T, Jeon YJ, Cui R, Lee JH, Peng Y, Kim SH, Tili E, Alder H, Croce CM.

J Natl Cancer Inst. 2015 Feb 6;107(4). pii: dju505. doi: 10.1093/jnci/dju505. Print 2015 Apr.

21.

Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.

Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim H, Park JK, Fadda P, Tili E, Nakanishi H, Huh MI, Kim SH, Cho JH, Sung BH, Peng Y, Lee TJ, Luo Z, Sun HL, Wei H, Alder H, Oh JS, Shim KS, Ko SB, Croce CM.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4173-8. doi: 10.1073/pnas.1400350111. Epub 2014 Mar 4.

22.

Genetic determinants and elements associated with antibiotic resistance in viridans group streptococci.

Brenciani A, Tiberi E, Tili E, Mingoia M, Palmieri C, Varaldo PE, Giovanetti E.

J Antimicrob Chemother. 2014 May;69(5):1197-204. doi: 10.1093/jac/dkt495. Epub 2013 Dec 15.

PMID:
24343896
23.

Characterization of Tn5801.Sag, a variant of Staphylococcus aureus Tn916 family transposon Tn5801 that is widespread in clinical isolates of Streptococcus agalactiae.

Mingoia M, Morici E, Tili E, Giovanetti E, Montanari MP, Varaldo PE.

Antimicrob Agents Chemother. 2013 Sep;57(9):4570-4. doi: 10.1128/AAC.00521-13. Epub 2013 Jul 1.

24.

MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.

Tili E, Michaille JJ, Croce CM.

Immunol Rev. 2013 May;253(1):167-84. doi: 10.1111/imr.12050. Review.

PMID:
23550646
25.

Resveratrol initiates differentiation of mouse skeletal muscle-derived C2C12 myoblasts.

Kaminski J, Lançon A, Aires V, Limagne E, Tili E, Michaille JJ, Latruffe N.

Biochem Pharmacol. 2012 Nov 15;84(10):1251-9. doi: 10.1016/j.bcp.2012.08.023. Epub 2012 Sep 5.

PMID:
22975027
26.

Identification of new binding partners of the chemosensory signaling protein Gγ13 expressed in taste and olfactory sensory cells.

Liu Z, Fenech C, Cadiou H, Grall S, Tili E, Laugerette F, Wiencis A, Grosmaitre X, Montmayeur JP.

Front Cell Neurosci. 2012 Jun 21;6:26. doi: 10.3389/fncel.2012.00026. eCollection 2012.

27.

The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.

Tili E, Michaille JJ, Luo Z, Volinia S, Rassenti LZ, Kipps TJ, Croce CM.

Blood. 2012 Sep 27;120(13):2631-8. Epub 2012 Jun 21.

28.

Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects.

Lançon A, Kaminski J, Tili E, Michaille JJ, Latruffe N.

J Agric Food Chem. 2012 Sep 12;60(36):8783-9. doi: 10.1021/jf301479v. Epub 2012 May 16. Review.

PMID:
22571175
29.

Resveratrol, MicroRNAs, Inflammation, and Cancer.

Tili E, Michaille JJ.

J Nucleic Acids. 2011;2011:102431. doi: 10.4061/2011/102431. Epub 2011 Aug 10.

30.

Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer.

Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4908-13. doi: 10.1073/pnas.1101795108. Epub 2011 Mar 7.

31.

Heterogeneity of Tn5253-like composite elements in clinical Streptococcus pneumoniae isolates.

Mingoia M, Tili E, Manso E, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2011 Apr;55(4):1453-9. doi: 10.1128/AAC.01087-10. Epub 2011 Jan 24.

32.

GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials.

Tili E, Michaille JJ, Liu CG, Alder H, Taccioli C, Volinia S, Calin GA, Croce CM.

Nucleic Acids Res. 2010 Nov;38(21):7673-88. doi: 10.1093/nar/gkq637. Epub 2010 Jul 17.

33.

Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells.

Tili E, Michaille JJ, Alder H, Volinia S, Delmas D, Latruffe N, Croce CM.

Biochem Pharmacol. 2010 Dec 15;80(12):2057-65. doi: 10.1016/j.bcp.2010.07.003. Epub 2010 Jul 15.

34.

Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.

Tili E, Michaille JJ, Adair B, Alder H, Limagne E, Taccioli C, Ferracin M, Delmas D, Latruffe N, Croce CM.

Carcinogenesis. 2010 Sep;31(9):1561-6. doi: 10.1093/carcin/bgq143. Epub 2010 Jul 9.

35.

miR-155: on the crosstalk between inflammation and cancer.

Tili E, Croce CM, Michaille JJ.

Int Rev Immunol. 2009;28(5):264-84. doi: 10.1080/08830180903093796. Review.

PMID:
19811312
36.

Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.

Costinean S, Sandhu SK, Pedersen IM, Tili E, Trotta R, Perrotti D, Ciarlariello D, Neviani P, Harb J, Kauffman LR, Shidham A, Croce CM.

Blood. 2009 Aug 13;114(7):1374-82. doi: 10.1182/blood-2009-05-220814. Epub 2009 Jun 11.

37.

MicroRNAs, the immune system and rheumatic disease.

Tili E, Michaille JJ, Costinean S, Croce CM.

Nat Clin Pract Rheumatol. 2008 Oct;4(10):534-41. doi: 10.1038/ncprheum0885. Epub 2008 Aug 26. Review.

PMID:
18728632
38.

Effects of fluoroquinolones on bacterial adhesion and on preformed biofilm of strains isolated from urinary double J stents.

Minardi D, Montanari MP, Tili E, Cochetti I, Mingoia M, Varaldo PE, Muzzonigro G.

J Chemother. 2008 Apr;20(2):195-201.

PMID:
18467245
39.

Expression and function of micro-RNAs in immune cells during normal or disease state.

Tili E, Michaille JJ, Calin GA.

Int J Med Sci. 2008 Apr 3;5(2):73-9. Review.

40.

erm(B)-carrying elements in tetracycline-resistant pneumococci and correspondence between Tn1545 and Tn6003.

Cochetti I, Tili E, Mingoia M, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2008 Apr;52(4):1285-90. doi: 10.1128/AAC.01457-07. Epub 2008 Feb 19.

41.

miRNAs and their potential for use against cancer and other diseases.

Tili E, Michaille JJ, Gandhi V, Plunkett W, Sampath D, Calin GA.

Future Oncol. 2007 Oct;3(5):521-37. Review.

PMID:
17927518
42.

Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock.

Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM.

J Immunol. 2007 Oct 15;179(8):5082-9.

43.

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas.

Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, Shimizu M, Tili E, Rossi S, Taccioli C, Pichiorri F, Liu X, Zupo S, Herlea V, Gramantieri L, Lanza G, Alder H, Rassenti L, Volinia S, Schmittgen TD, Kipps TJ, Negrini M, Croce CM.

Cancer Cell. 2007 Sep;12(3):215-29.

44.

Composite structure of Streptococcus pneumoniae containing the erythromycin efflux resistance gene mefI and the chloramphenicol resistance gene catQ.

Mingoia M, Vecchi M, Cochetti I, Tili E, Vitali LA, Manzin A, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2007 Nov;51(11):3983-7. Epub 2007 Aug 20.

45.

New Tn916-related elements causing erm(B)-mediated erythromycin resistance in tetracycline-susceptible pneumococci.

Cochetti I, Tili E, Vecchi M, Manzin A, Mingoia M, Varaldo PE, Montanari MP.

J Antimicrob Chemother. 2007 Jul;60(1):127-31. Epub 2007 May 5.

PMID:
17483548
46.

Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition.

Mao C, Tili EG, Dose M, Haks MC, Bear SE, Maroulakou I, Horie K, Gaitanaris GA, Fidanza V, Ludwig T, Wiest DL, Gounari F, Tsichlis PN.

J Immunol. 2007 May 1;178(9):5443-53.

47.

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, Croce CM.

Proc Natl Acad Sci U S A. 2006 May 2;103(18):7024-9. Epub 2006 Apr 25.

48.

Molecular characterization of pneumococci with efflux-mediated erythromycin resistance and identification of a novel mef gene subclass, mef(I).

Cochetti I, Vecchi M, Mingoia M, Tili E, Catania MR, Manzin A, Varaldo PE, Montanari MP.

Antimicrob Agents Chemother. 2005 Dec;49(12):4999-5006.

49.
50.

Interpretive criteria for disk diffusion susceptibility testing of ulifloxacin, the active metabolite of prulifloxacin.

Montanari MP, Ferrante L, Tili E, Cochetti I, Rossi V, Varaldo PE.

J Chemother. 2005 Apr;17(2):138-42.

PMID:
15920898

Supplemental Content

Support Center